
DBD Stock Forecast & Price Target
DBD Analyst Ratings
Bulls say
Diebold Nixdorf is experiencing an anticipated increase in Retail sales in Europe, projected to grow both sequentially and year-over-year in the upcoming quarters. The company is showing a strong financial performance with sustainably positive free cash flow (FCF), expected to nearly double by 2025, reaching an estimated $205 million. Additionally, Diebold Nixdorf's balance sheet and liquidity are reported to be in their best condition in recent history, supporting a favorable outlook for enhanced FCF conversion.
Bears say
Diebold Nixdorf Inc faces significant challenges that present a negative outlook for its stock, primarily due to vulnerability to tariff-related costs and a volatile trade environment, which could adversely impact financial forecasts. Additionally, the company is experiencing disruptions in its supply chain and logistical operations, compounded by lower than anticipated upgrade and replacement activities in its Banking vertical, leading to potential revenue volatility. Furthermore, currency fluctuations and liquidity concerns, characterized by a low average daily trading volume, may further contribute to negative sentiment surrounding the company's financial stability.
This aggregate rating is based on analysts' research of Diebold Nixdorf Inc and is not a guaranteed prediction by Public.com or investment advice.
DBD Analyst Forecast & Price Prediction
Start investing in DBD
Order type
Buy in
Order amount
Est. shares
0 shares